Chronic Disease

Challenged by MS, the “Spice-Trekkers” Discover Their Own Culinary Medicine

By Ellen Kanner, Contributing Writer

Philippe and  Ethné de Vienne an explorer by nature. He and his wife Ethné travel the world, sourcing organic spices and herbs where they’re grown. That’s their job as the owners of the Montreal-based spice company, Épices de Cru. But five years ago, when Philippe was suddenly diagnosed with Multiple Sclerosis, their search took a very different turn–one that led to important discoveries about how to use foods and spices to alter the course of serious autoimmune diseases.

To Reverse Alzheimer’s, Seek its Triggers: An Interview with Dale Bredesen, MD

By Erik Goldman, Editor

Alzheimer’s disease is largely preventable, and often reversible. Those are bold statements, especially from a conventionally-trained neurologist. But Dale Bredesen, MD, is used to challenging orthodox views. In this in-depth interview article, Dr. Bredesen shares his perspective–drawn from more than 30 years’ clinical and research experience–on how to avert the “long goodbye” of dementia.

The Fed’s Misguided “War on Pain,” And What We Can Do Instead

By Jacob Teitelbaum, MD, Contributing Writer

About a decade ago, with roughly one-quarter of all Americans suffering some form of chronic pain, the US government did what it does best, and declared a “War on Pain.” Doctors responded by doing what they do best: prescribing painkillers. The result? Thousands of preventable deaths due to overdoses and side-effects, a surge of addiction, and even more people in chronic pain. Fortunately, as pain expert Jacob Teitelbaum points out, holistic and integrative medicine offers many safer, more effective options.

Anti-Inflammatory Side-Effects Carry High Price Tag

By Rachael Adams, Contributing Writer

Anti-inflammatory drugs hold the top spot for specialty drug spending in the US, accounting for 23% of all dollars spent on specialty medications. They’re also among the most common culprits when it comes to adverse effects, and those end up costing us billions—$2.2 billion to be exact.